Regulation of Hepatic Insulin Extraction (RHIE)

Regulation of Hepatic Insulin Extraction:Alterations of Insulin Secretion in Subjects With Genetic Variants That Determine Risk for Non-Insulin Dependant Diabetes Mellitus

  • This study is in the area of Type 2 diabetes and genetics
  • Healthy Volunteers and those with mild type 2 diabetes may be eligible to participate
  • This study is searching for genes that may affect the body's processing/digestion of glucose/sugar

Study Overview

Status

Withdrawn

Conditions

Detailed Description

This study is looking at the genetic influences of type 2 diabetes. It also is investigating the various gastric hormones including but not limited to: insulin, C-peptide, GIP, GLP, & Xenin.

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy Volunteers & otherwise healthy diabetic volunteers (do not require insulin for glucose control).

Description

Inclusion Criteria:

  • ages 18-65
  • non-diabetic
  • diabetes controlled with diet or with pills
  • no family history of diabetes
  • family history of type 2 diabetes
  • personal history of gestational diabetes

Exclusion Criteria:

  • < 18 or > 65 years of age
  • medications that affect glucose (sugar) levels
  • kidney disease
  • liver disease
  • heart/cardiovascular disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Entry
This group is just entering the study and will need to be genotyped.
Affected
This group has been genotyped and has the gene undergoing study at that time.
Control
This group has been genotyped and does not have the gene currently under study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Genes affecting the development of Type 2 diabetes will be identified
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Any differences between genetic groups in the metabolism of glucose/sugar will be studied to the extent that the data allow
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2000

Primary Completion (Anticipated)

June 1, 2015

Study Completion (Anticipated)

June 1, 2015

Study Registration Dates

First Submitted

December 17, 2008

First Submitted That Met QC Criteria

December 17, 2008

First Posted (Estimate)

December 18, 2008

Study Record Updates

Last Update Posted (Actual)

June 27, 2018

Last Update Submitted That Met QC Criteria

June 25, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 00-0589
  • 5R01DK031842-26 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

3
Subscribe